NASDAQ:MDSO - Medidata Solutions Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $75.47 +0.50 (+0.67 %) (As of 02/22/2019 04:00 PM ET)Previous Close$74.97Today's Range$74.97 - $75.8552-Week Range$60.10 - $88.87Volume400,500 shsAverage Volume538,739 shsMarket Capitalization$4.62 billionP/E Ratio78.61Dividend YieldN/ABeta1.32 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner and ongoing support, and e-learning and training. The company markets and sells its cloud-based solutions through a direct sales force, as well as through relationships with contract research organizations (CROs) and other strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; and CROs and other entities engaged in clinical trials. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York. Receive MDSO News and Ratings via Email Sign-up to receive the latest news and ratings for MDSO and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Prepackaged software Sub-IndustryHealth Care Technology SectorMedical Current SymbolNASDAQ:MDSO Previous Symbol CUSIP58471A10 CIK1453814 Webwww.mdsol.com Phone212-918-1800Debt Debt-to-Equity Ratio0.14 Current Ratio2.71 Quick Ratio2.52Price-To-Earnings Trailing P/E Ratio78.61 Forward P/E Ratio94.34 P/E Growth5.09 Sales & Book Value Annual Sales$635.70 million Price / Sales7.26 Cash Flow$1.7009 per share Price / Cash Flow44.37 Book Value$10.32 per share Price / Book7.31Profitability EPS (Most Recent Fiscal Year)$0.96 Net Income$51.92 million Net Margins8.17% Return on Equity10.03% Return on Assets5.85%Miscellaneous Employees1,680 Outstanding Shares61,190,000Market Cap$4.62 billion Next Earnings Date4/18/2019 (Estimated) OptionableOptionable Medidata Solutions (NASDAQ:MDSO) Frequently Asked Questions What is Medidata Solutions' stock symbol? Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO." How were Medidata Solutions' earnings last quarter? Medidata Solutions Inc (NASDAQ:MDSO) released its earnings results on Tuesday, February, 12th. The company reported $0.45 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.37 by $0.08. The firm earned $167.19 million during the quarter, compared to analysts' expectations of $168.08 million. Medidata Solutions had a net margin of 8.17% and a return on equity of 10.03%. The business's quarterly revenue was up 18.1% compared to the same quarter last year. During the same period in the prior year, the company earned $0.41 EPS. View Medidata Solutions' Earnings History. When is Medidata Solutions' next earnings date? Medidata Solutions is scheduled to release their next quarterly earnings announcement on Thursday, April 18th 2019. View Earnings Estimates for Medidata Solutions. What guidance has Medidata Solutions issued on next quarter's earnings? Medidata Solutions issued an update on its FY 2019 earnings guidance on Tuesday, February, 12th. The company provided earnings per share (EPS) guidance of $1.71-1.82 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.84. The company issued revenue guidance of $734-746 million, compared to the consensus revenue estimate of $749.49 million. What price target have analysts set for MDSO? 10 brokers have issued 1-year price targets for Medidata Solutions' shares. Their predictions range from $70.00 to $90.00. On average, they expect Medidata Solutions' stock price to reach $83.70 in the next twelve months. This suggests a possible upside of 10.9% from the stock's current price. View Analyst Price Targets for Medidata Solutions. What is the consensus analysts' recommendation for Medidata Solutions? 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medidata Solutions in the last year. There are currently 1 sell rating, 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Medidata Solutions. Has Medidata Solutions been receiving favorable news coverage? Headlines about MDSO stock have trended somewhat positive on Saturday, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Medidata Solutions earned a media sentiment score of 1.7 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the near future. Who are some of Medidata Solutions' key competitors? Some companies that are related to Medidata Solutions include Veeva Systems (VEEV), Synopsys (SNPS), Cadence Design Systems (CDNS), SS&C Technologies (SSNC), ANSYS (ANSS), Symantec (SYMC), Citrix Systems (CTXS), Twilio (TWLO), Atlassian (TEAM), Tableau Software (DATA), PTC (PTC), Micro Focus International (MFGP), Paycom Software (PAYC), The Ultimate Software Group (ULTI) and Dropbox (DBX). What other stocks do shareholders of Medidata Solutions own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medidata Solutions investors own include NVIDIA (NVDA), salesforce.com (CRM), Alphabet (GOOG), Celgene (CELG), Applied Materials (AMAT), Alibaba Group (BABA), Netflix (NFLX), Tesla (TSLA), Twitter (TWTR) and Splunk (SPLK). Who are Medidata Solutions' key executives? Medidata Solutions' management team includes the folowing people: Mr. Tarek A. Sherif, Co-Founder, Chairman & CEO (Age 57)Mr. Glen M. De Vries, Co-Founder, Pres & Director (Age 47)Mr. Rouven Bergmann, CFO & Chief Accounting Officer (Age 46)Mr. Michael I. Otner, Exec. VP, Gen. Counsel & Sec. (Age 48)Mr. Michael Pray, Exec. VP of Sales (Age 53) Who are Medidata Solutions' major shareholders? Medidata Solutions' stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (11.43%), Bank of New York Mellon Corp (2.41%), Canada Pension Plan Investment Board (1.81%), Royce & Associates LP (1.79%), Nikko Asset Management Americas Inc. (1.76%) and Global Thematic Partners LLC (1.62%). Company insiders that own Medidata Solutions stock include Carlos Dominguez, Lee Shapiro, Michael I Otner, Michael L Capone, Michael Pray, Robert Taylor, Rouven Bergmann, Tarek Sherif and Vries Glen Michael De. View Institutional Ownership Trends for Medidata Solutions. Which major investors are selling Medidata Solutions stock? MDSO stock was sold by a variety of institutional investors in the last quarter, including Polen Capital Management LLC, Eagle Asset Management Inc., Global Thematic Partners LLC, Brown Advisory Inc., New York State Common Retirement Fund, Frontier Capital Management Co. LLC, First Quadrant L P CA and Bank of New York Mellon Corp. Company insiders that have sold Medidata Solutions company stock in the last year include Lee Shapiro, Michael I Otner, Michael Pray, Robert Taylor, Rouven Bergmann and Tarek Sherif. View Insider Buying and Selling for Medidata Solutions. Which major investors are buying Medidata Solutions stock? MDSO stock was purchased by a variety of institutional investors in the last quarter, including Nikko Asset Management Americas Inc., BlackRock Inc., Polar Capital LLP, Royce & Associates LP, Dimensional Fund Advisors LP, Rhumbline Advisers, Ranger Investment Management L.P. and Prudential PLC. View Insider Buying and Selling for Medidata Solutions. How do I buy shares of Medidata Solutions? Shares of MDSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Medidata Solutions' stock price today? One share of MDSO stock can currently be purchased for approximately $75.47. How big of a company is Medidata Solutions? Medidata Solutions has a market capitalization of $4.62 billion and generates $635.70 million in revenue each year. The company earns $51.92 million in net income (profit) each year or $0.96 on an earnings per share basis. Medidata Solutions employs 1,680 workers across the globe. What is Medidata Solutions' official website? The official website for Medidata Solutions is http://www.mdsol.com. How can I contact Medidata Solutions? Medidata Solutions' mailing address is 350 HUDSON ST. 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 212-918-1800 or via email at [email protected] MarketBeat Community Rating for Medidata Solutions (NASDAQ MDSO)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 437 (Vote Outperform)Underperform Votes: 339 (Vote Underperform)Total Votes: 776MarketBeat's community ratings are surveys of what our community members think about Medidata Solutions and other stocks. Vote "Outperform" if you believe MDSO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDSO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/23/2019 by MarketBeat.com StaffFeatured Article: What is an SEC Filing?